Abstract
Combined structure and ligand-based design of dual BACE-1/GSK-3β inhibitors for Alzheimer’s disease
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have